An endogenous 105-kDa plasma glycoprotein produced primarily by the liver and monocytes. It inhibits a broad spectrum of proteases, including the complement c1r and the complement c1s proteases of the CLASSICAL COMPLEMENT PATHWAY, and the mannose-binding protein-associated serine proteases. C1-INH-deficient individuals suffer from hereditary angioedema types i and ii.